Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial.

Teng MaRongrong HuangYanhua XuYangbo LvYifan LiuXin PanJia DongDi GaoZeyu WangFenglei ZhangChunxi YanSang-Bing OngYang SuDachun Xu

Published in: Journal of translational medicine (2023)

Elevated plasma GAS6 levels were associated with an increased risk of all-cause and cardiovascular death in patients with AHF. Trial registration NCT03727828 (DRAGON-HF trial) clinicaltrials.gov.

Keyphrases

acute heart failure
phase iii
study protocol
phase ii
clinical trial
heart failure
end stage renal disease
newly diagnosed
ejection fraction
room temperature
prognostic factors
peritoneal dialysis
patient reported outcomes